Table 1 Baseline Characteristics in each treatment group
Variables n = 36 | Group 1 n = 18 | Group 2 n = 18 | P-Value | |
|---|---|---|---|---|
Mean ± SD | Mean ± SD | |||
Age (Years) | 47.22 ± 14.17 | 53.89 ± 14.11 | 0.17 | |
Duration of Known Hepatitis C (Years) | 4.61 ± 3.84 | 3.55 ± 1.92 | 0.31 | |
Duration of Dialysis (Years) | 4.23 ± 2.63 | 5.33 ± 2.79 | 0.23 | |
HCV RNA PCR (log 10 IU/ml) | 5.88 ± 6.0 | 6.16 ± 6.58 | 0.46 | |
Gender | Male | N = 11 | N = 11 | ___ |
Female | N = 7 | N = 7 | ||
Genotype 1 Patients | N = 06 | N = 06 | ___ | |
Genotype 2 Patients | N = 00 | N = 01 | ___ | |
Genotype 3 Patients | N = 12 | N = 11 | ___ | |
Cirrhosis | N = 04 | N = 06 | ___ | |
Treatment Experienced | N = 03 | N = 02 | ___ | |
Treatment Withdrawal | N = 03 | N = 01 | ___ | |
Aspartate Aminotransferase (U/L) | 57.06 ± 48.71 | 34.5 ± 25.27 | 0.09 | |
Alanine Aminotransferase (U/L) | 50.89 ± 44.08 | 40.50 ± 34.86 | 0.44 | |
Hemoglobin (g/dl) | 10.53 ± 1.61 | 11.51 ± 1.15 | 0.04 | |
White Blood Cells × 103/mm3 | 6.33 ± 1.93 | 6.44 ± 1.91 | 0.87 | |
Platelets ×103/mm3 | 163.27 ± 65.34 | 175.44 ± 40.11 | 0.51 | |
Independent t-test was used to assess the significance | ||||